NCT02256527已完成不适用
REWARDS-Premier TLX (Registry Experience at the WAshington Hospital CenteR, DeS - Premier Taxus-Liberte vs Xience V)
Medstar Health Research Institute1 个研究点 分布在 1 个国家目标入组 917 人开始时间: 2014年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 917
- 试验地点
- 1
- 主要终点
- Major adverse cardiac event
研究概览
简要总结
Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 years of age or older
- •Underwent PCI with Promus Premier (alone) DES
排除标准
- •Underwent PCI with a non-Promus Premier DES during the same index procedure
- •Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel, prasugrel, or ticagrelor)
结局指标
主要结局
Major adverse cardiac event
时间窗: 1 year
composite of all-cause death, Q-wave myocardial infarction, and target vessel revascularization
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience VCoronary Artery DiseaseNCT01134159Medstar Health Research Institute1,200
已完成
不适用
ClearWay™ RX Registry TrialHeart DiseasesVascular DiseasesNCT00804024Atrium Medical Corporation102
已完成
不适用
REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFECongestive Heart FailureNCT01369407University of Michigan400
Unknown
不适用
AMBULATE Same Day Discharge RegistryVascular ClosureNCT04203329Cardiva Medical, Inc.700
招募中
不适用
Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese PatientsAortic Valve Disease MixedNCT06257043Xijing Hospital3,000